<DOC>
	<DOCNO>NCT02910167</DOCNO>
	<brief_summary>What AE occur routine clinical practice , incidence AE ADR , many patient present AE symptom related potential liver injury . What drug utilization pattern patient , predispose factor occurrence adverse event adverse drug reaction .</brief_summary>
	<brief_title>Observational Prospective Study Evaluate AEs , Risk Factors Drug Utilization BUSCAPINA COMPOSITUM N Adults From Metropolitan Lima</brief_title>
	<detailed_description />
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients 18 year age old receive least one dose BUSCAPINA COMPOSITUM N accord label indication attend one pharmacy , clinic , private doctor office select study . 2 . Patients agree adhere protocol procedure study . 3 . Women pregnant breast feed 4 . Persons sign inform consent Exclusion criterion : 1 . Patients allergy BUSCAPINA COMPOSITUM N compound formula . 2 . Patients mechanical stenosis gastrointestinal tract . 3 . Patients myasthenia gravis . 4 . Patients megacolon . 5 . Patients breastfeed time enrollment become pregnant treatment BUSCAPINA COMPOSITUM N. 6 . Patients clinical evidence immunosuppression . 7 . Patients urinary retention subvesical obstruction ( prostatic adenoma ) . 8 . Patients rightangle glaucoma . 9 . Patients tachycardia tachyarrhythmia . 10 . Patients severe hepatic impairment . 11 . Patients psychiatric disorder . 12 . Patients alcohol dependence drug . 13 . Patients discontinue protocol eligible reenrollment . 14 . Researchers , company personnel relative .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>